Amelia Zellander

Executive Officer, Director at BioLattice Ophthalmics.

Raised on BioLattice Ophthalmics filings

$575K

of $2.5M offered across 1 Form D filing

Company

Biotech · Philadelphia, PA

Synthetic cornea implant to replace donor tissue

Synthetic cornea implant to replace donor tissue

BioLattice Ophthalmics Form D filings
Filed	Security	Sold of offered	Filing
Mar 30, 2026	Equity	$575K/ $2.5M	Form D

Also named on BioLattice Ophthalmics filings